Oklahoma City Dispensary Becomes a Unity Rd. Local Alliance Partner
January 27th, 2022
National Cannabis Dispensary Franchise Progresses Midwest Growth; Local Alliance Program Aims to Keep Dispensary Ownership Local by Providing Existing Owners the Backing of a National Franchise System
OKLAHOMA CITY, Jan. 27, 2022 /PRNewswire/ — Unity Rd., the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), announced today it has signed its first partner through its Local Alliance Program with an Oklahoma City dispensary, Ringside Medical. The shop is located at 14201 N. May Ave. #205 and will be rebranded to Unity Rd.
Unity Rd. launched the Local Alliance Program in 2021 to support local dispensary ownership. Through the program, existing cannabis dispensary owners and license holders can partner with Unity Rd. to gain direct access to the buying power, resources and supportive network normally reserved for multi-unit operators. Partners through this program retain 100% ownership of their dispensary license and business and benefit from the tools, expertise and ongoing support necessary to compliantly and successfully operate a dispensary.
“The U.S. cannabis landscape is comprised of small, independent entrepreneurs and giant, multi-state operators,” said Unity Rd.’s Chief Franchise Officer Mike Weinberger. “With the added layer of complexities that cannabis brings by being federally illegal and so highly regulated, it is challenging for independents to compete with conglomerates that have teams of industry experts who are dedicated to compliance, accounting, marketing, etc. and know how to navigate the intricacies of cannabis.”
Weinberger continued, “The franchise model gives prospective and existing dispensary owners a fighting chance by empowering them with the knowledge, relationships and ongoing support they need to be compliant and focused on growing their business, rather than stuck in day-to-day management.”
“Having the supportive network of a franchise will be a tremendous weight off us and our team,” said Ringside Medical Co-Owner Robin O’Grady. “Cannabis is complicated. You need to constantly be on your toes and able to pivot at a moment’s notice. By joining Unity Rd., we’re expanding our team with experts who have operated cannabis businesses in multiple states and gaining several other benefits that will positively impact our future growth.”
The Local Alliance shop is primed for growth as Oklahoma’s medical cannabis market has surpassed $1.5 billion in revenue since legal sales began in 2018. The state has one of the largest medicinal programs in the U.S. with about 10% of the population, nearly four million residents, having obtained a medical card. Further, Oklahoma activists have already filed two ballot measures this year to legalize adult-use cannabis and overhaul the state’s medical cannabis system.
“We’re hopeful this Local Alliance shop will be the first of many Unity Rd. shops across Oklahoma,” said the marijuana franchise’s Vice President of Franchise Development Justin Livingston. “We’re confident that our team can help owners increase their dispensary’s value within their local communities.”
In addition to Oklahoma, the cannabis franchise is actively seeking partnerships with existing dispensary owners across the United States who would benefit from the systems, processes and ongoing support the franchise offers. Unity Rd. also partners with industry newcomers and currently has multiple agreements signed with nearly 20 entrepreneurial groups who are in various stages of development nationwide. The franchise offers one of the safest routes for cannabis entrepreneurs looking to stake their claim in the fast-growing, complex industry. Backed by time-tested Standard Operating Procedures (SOPs) and an accomplished team boasting more than 200 years of combined experience in cannabis and franchising, franchise partners are guided through every operational function of the business – whether it be assisting with cash flow, product selection or changing regulations.
To learn more about the Unity Rd. Local Alliance Program, contact firstname.lastname@example.org or call 480-542-9420.
For more information about the Unity Rd. Franchise Opportunity, contact email@example.com, call 720-923-5262 or visit unityrd.com.
About Unity Rd.
Unity Rd. is bridging the two previously disconnected worlds of cannabis and franchising. The industry trailblazer is the first to bring the cannabis dispensary franchise model to the United States—with duality of prowess in both industries to back it up. Built up from a collective 200 years in the legal cannabis industry and franchising, the company helps eager operators enter the complex industry with ease. The marijuana franchise pioneer offers its partners the knowledge, resources, and ongoing support needed to compliantly and successfully operate a dispensary. Launched in 2018, Unity Rd. has signed multiple agreements with nearly 20 entrepreneurial groups across the country. Recently, it was named one of the top cannabis retail leaders in the nation by MJBizDaily magazine and one of the “Best Cannabis Companies to Work For” in both the dispensary and cultivation categories in Cannabis Business Times’ elite 2020 list. The company is also the first cannabis business to earn a Franchise Times Dealmakers award. For more information, visit unityrd.com.
About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space by 650,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.
Item 9 Labs Corp.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.